Abstract
The cytokine interleukin-1 (IL-1) is a hormone-like polypeptide that performs many roles in inflammation and immunity.1–3 Currently, two forms of IL-1 (IL-1α and IL-1β) and one IL-1 receptor antagonist (IL-1ra) have been characterized.1 In addition to its immune effects, a role has been postulated for IL-1 as a neurotransmitter/neuromodulator/growth factor in the central nervous system (CNS). IL-1 production has been reported in cultured brain astrocytes and microglia4–6 and IL-1 has been detected in the brain following cerebral trauma7,8 and endotoxin treatment.9 IL-1-like activity is also present in the cerebrospinal fluid (CSF),10,11 IL-1 mRNA is present in normal brain,12,13 and immunohistochemical studies have identified neurons positive for IL-1 β-like immunoreactivity in both hypothalamic14,15 and extrahypothalamic14 sites in human brain. Administration of IL-1 in brain produces a variety of effects, including induction of fever,1–3 alteration of slow-wave sleep,16,17 reduction of food intake,18 induction of analgesia,19 induction of acute-phase glycoprotein synthesis,20,21 stimulation of thermogenesis22,23 and reduction of peripheral cellular immune responses.24 Central as well as peripheral administration of IL-1 has potent neuroendocrine actions including stimulation of the hypothalamic-pituitary-adrenocortical axis25–27 and inhibition of the hypothalamic-pituitary-gonadal axis.28
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627–52.
Mizel SB. The interleukins. FASEB J 1989; 3: 2379–88.
Oppenheim JJ, Kovacs EJ, Matsushima K et al. There is more than one interleukin 1. Immmunol Today 1986; 7: 45–6.
Fontana A, Kristensen F, Dubs R et al. Production of prostaglandin and interleukin-1 like factor by cultured astrocytes and glioma cells. J Immunol 1982; 129: 2413–9.
Giulian D, Baker TJ, Shih LC et al. Interleukin 1 of the central nervous system is produced by ameboid microglia. J Exp Med 1986; 164: 594–604.
Giulian D, Young DG, Woodward J et al. Interleukin-1 is an astroglial growth factor in the developing brain. J Neurosci 1988; 8: 709–14.
Giulian D, Lachman LB. Interleukin-1 stimulates astroglial proliferation after brain injury. Science 1985; 228: 497–9.
Perry VH, Brown MC, Gordon S. The macrophage response to central and peripheral nerve injury: A possible role for macrophage in regeneration. J Exp Med 1987; 165: 1218–23.
Fontana A, Weber E, Dayer JM. Synthesis of interleukin-1/endogenous pyrogen in the brain of endotoxin treated mice: a step in fever induction. J Immunol 1984; 133: 1696–8.
Lue FA, Bail M, Gorczynski R et al. Sleep and interleukin-1-like activity in cat cerebrospinal fluid. Int J Neurosci 1988; 42: 179–83.
Mustafa MM, Lebel MH, Ramio O et al. Correlation of interleukin-1 (3 and cachectin concentrations in cerebrospinal fluid and outcome from bacterial meningitis. J Pediatr 1989; 115: 208–13.
Farrar WL, Hill JM, Harel-Bellan A et al. The immune logical brain. Immunol Rev 1987; 100: 361–8.
Heier E, Ayala J, Denefle A et al. Brain macrophages synthesize interleukin- 1 and interleukin-1 mRNA in vitro. J Neurosci Res 1988; 21: 391–7.
Breder CD, Dinarello CA, Saper CB. Interleukin-1 immunoreactive innervation of the human hypothalamus. Science 1988; 240: 321–4.
Breder CD, Saper CB. Interleukin-1 β-like immunoreactive innervation in the human central nervous system. Soc Neurosci Abstr 1989; 15: 715.
Krueger JM, Walter J, Dinarello CA et al. Sleep-promoting effects of endogenous pyrogen (interleukin-1). Am J Physiol 1984; 246: R994–9.
Tobler I, Borbely AA, Schwyzer M et al. Interleukin-1 derived from astrocytes enhances slow wave activity in sleep EEG of the rat. Eur J Pharmacol 1984; 104: 191–2.
McCarthy DO, Kluger MJ, Vander AJ. Suppression of food intake during infection: is interlexukin-1 involved? Am J Clin Nutr 1985; 42: 181–4.
Nakamura H, Nakanishi S, Kita A et al. Interleukin-1 induces analgesia in mice by a central action. Eur J Pharmacol 1988; 159: 49–54.
Kampschmidt RF. The numerous postulated biological manifestations of interleukin-1. J Leukoc Biol 1984; 36: 341–55.
Blatteis CM. Neural mechanisms in the pyrogenic and acute-phase responses to interleukin-1. Int J Neurosci 1988; 38: 223–32.
Dascombe MJ, Hardwick A, Lefeuvre RA et al. Impaired effects of interleukin-1 beta on fever and thermogenesis in genetically obese rats. Int J Obes 1989; 13: 367–73.
Busbridge NJ, Dascombe MJ, Tilders FJ et al. Central activation of thermogenesis and fever by interleukin-1 beta and interleukin-1 alpha involves different mechanisms. Biochem Biophys Res Commun 1989; 162: 591–6.
Sundar SK, Cicerpial MA, Kilts C et al. Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor. J Neurosci 1990; 10: 3701–6.
Berkenbosch F, Van Oers J, Del Rey A et al. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238: 524–6.
Sapolsky R, Rivier C, Yamamoto G et al. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987; 238: 522–4.
Uehara A, Gottschall PE, Dahl RR et al. Interleukin-1 stimulates ACTH lnterleukin-1 Receptors in the Nervous System release by an indirect action which requires endogenous corticotropin-releasing factor. Endocrinology 1987; 121: 1580–2.
Rivier C, Vale W. In the rat, interleukin-la acts at the level of the brain and the gonads to interfere with gonadotropin and sex steroid secretion. Endocrinology 1989; 124: 2105–9.
Sims JE, March CJ, Cosman D et al. cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 1988; 241: 585–9.
Sims JE, Acres RB, Grubin C. Cloning the interleukin 1 receptor from human T cells. Proc Natl Acad Sci USA 1989; 86: 8946–50.
McMahan CJ, Slack JL, Mosley B et al. A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO 1991; 10: 2821–32.
Yanagisawa K, Takagi T, Tsukamoto T et al. Presence of a novel primary response gene ST2L, encoding a product highly similar to the interleukin 1 receptor type 1. FEBS Lett 1993; 318: 83–7.
Bergers G, Reikerstorfer A, Braselmann S et al. Alternative promoter usage of Fos-resposive gene Fit-1 generates mRNA isoforms coding for either secreted or membrane-bound proteins related to the IL-1 receptor. EMBO 1994; 13: 1176–88.
Lovenberg TW, Crowe PD, Liu C et al. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL-lR-rp). J Neuroimmunol 1996; (in press).
Greenfeder SA, Nunes P, Kwee L et al. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem 1995; 270: 13757–65.
Hart RP, Liu C, Shadiack AM et al. An mRNA homology to interleukin- 1 receptor type I is expressed in cultured rat sympathetic ganglia. J Neuroimmunol 1993; 44: 49–56.
Bristulf J, Gatti S, Malinowsky D et al. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA. Eur Cytokine Netw 1994; 5: 319–330.
Liu C, Chalmers DT, Maki R et al. Rat homolog of mouse interleukin-1 receptor accessory protein: cloning, localization and modulation studies. J Neuroimmunol 1996; 66: 41–8.
Alcami A, Smith GL. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 1992; 71: 153–67.
Liu C, Ganea D, Hart RP. A soluble IL-1 receptor is expressed in cultured rat sympathetic ganglia from the type I IL-1 receptor gene. Soc Neurosci Abstr 1993; 19: 95.
Liu C, Hart RP, Liu X-J et al. Cloning and characterization of an alternatively processed human type II interleukin-1 receptor mRNA. J Biol Chem 1996; 271: 20965–72.
Yanagisawa K, Tsukamoto T, Takagi T et al. Murine ST2 gene is a member of the primary response gene family induced by growth factors. FEBS Lett 1992; 302: 51–3.
Sims JE, Gayle MA, Slack JL et al. Inetrleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 1993; 90: 6155–9.
Colotta F, Re F, Muzio M et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science 1993; 261: 472–5.
Muegge K, Williams TM, Kant J et al. Interleukin-1 costimulatary activity on the interleukin-2 promoter via AP-1. Science 1989; 246: 249–51.
Muegge K, Durum SK. Cytokines and transcription factors. Cytokine 1990; 2: 1 - 8.
Muegge K, Vila M, Gusella GL et al. Interleukin 1 induction of the c- jun promoter. Proc Natl Acad Sci USA 1993; 90: 7054–8.
Bomsztyk K, Sims JE, Stanton TH et al. Evidence for different interleukin 1 receptors in murine B- and T-cell lines. Proc Natl Acad Sci USA 1989; 86: 8034–8.
Mathias S, Younes A, Kan C-C et al. Activation of the sphingomyelin signal pathway in intact EL4 cells and in a cell-free system by IL-1 β. Science 1993; 359: 519–22.
Cao Z, William JH, Gao X. IRAK: a kinase associated with the interleukin- I receptor. Science 1996; 271: 1128–31.
Letsou A, Alexander S, Orth K, et al. Genetic and molecular characterization of tube, a Drosophila gene maternally required for embryonic dors- oventral polarity. Proc Natl Acad Sci USA 1991; 88: 810–4.
Shelton CA, Wasserman SA. Pelle encodes a protein kinase required to establish dorsoventral polarity in the Drosophila embryo. Cell 1993; 72: 515–25.
Luheshi G, Hopkins SJ, Lefeuvre RA et al. Importance of brain IL-1 type II receptors in fever and thermogenesis in the rat. Am J Physiol 1993; 265: E585–91.
Takao T, Tracey DE, Mitchell WM et al. Interleukin-1 receptors in mouse brain: Characterization and neuronal localization. Endocrinology 1990; 127: 3070–8.
Takao T, Newton RC, De Souza EB. Species differences in [125I]interleukin-1 binding in brain, endocrine and immune tissues. Brain Res 1993; 623: 172–6.
Opp MR, Obal F Jr, Krueger JM. Interleukin-1 alters rat sleep: temporal and dose-related effect. Am J Physiol 1991; 260: R52–8.
Hellerstein MK, Meydani SN, Meydani M et al. Interleukin-1-induced anorexia in the rat. J Clin Invest 1989; 84: 228–35.
Katsuura G, Arimura A, Koves K et al. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin lβ-induced ACTH release. Am J Physiol 1990; 258: E163–71.
Rivier C, Vale W. Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: Is it modulated by prostaglandins? Endocrinology 1991; 129: 384–8.
Dinarello CA, Thompson RC. Blocking IL-1: interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 1991; 12: 404–10.
Marquette C, Van Dam AM, Ban E, et al. Rat interleukin-1 beta binding sites in rat hypothalamus and pituitary gland. Neuroendocrinology 1995; 62: 362–9.
Takao T, Culp SG, Newton RC et al. Type I interleukin-1 (IL-1) receptors in the mouse brain-endocrine-immune axis labelled with 1251-recombinant human IL-1 receptor antagonist. J Neuroimmunol 1992; 41: 51–60.
Gery I, Gershon RK, Waksman BH. Potentiation of the T-lymphocyte response to mitogens I. The responding cell. J Exp Med 1972; 136: 128–42.
Munson PJ, Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980; 297: 220–9.
Ericsson A, Liu C, Kasckow J et al. Type I interleukin-1 receptor in rat brain: distribution, regulation, and relationship to sites of IL-1 induced cellular activation. J Comp Neurol 1995; 361: 681–98.
Cunningham ET Jr, Wada E, Carter DB, et al. Localization of interleukin- 1 receptor messenger RNA in murine hippocampus. Endocrinology 1991; 128: 2666–8.
Cunningham ET Jr, Wada E, Carter DB et al. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary and adrenal gland of the mouse. J Neurosci 1992; 12: 1101–14.
Boulant JA, Demieville HN. Responses of thermosensitive preoptic and septal neurons to hippocampal and brain stem stimulation. J Neurophysiol 1977; 40: 1356–68.
Hori T, Osaka T, Kiyohara T et al. Hippocampal input to preoptic thermosensitive neurons in the rat. Neurosci Lett 1982; 32: 155–8.
Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev 1991; 12: 118–34.
Keller-Wood M, Dallman M. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984; 5: 1–24.
Navarra P, Tsagarakis S, Fara MS et al. Interleukin-1 and -6 stimulate the release of corticotropin-releasing hormone-4l from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991; 128: 37–44.
Tsagarakis S, Gillies G, Rees LH et al. Interleukin-1 directly stimulates the release of corticotropin releasing factor from rat hypothalamus. Neuroendocrinology 1989; 49: 98–101.
Sharp BM, Matta SG, Peterson PK et al. Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1 beta. Endocrinology 1989; 124: 3131–5.
Yabuuchi K, Minami M, Katsumata S et al. Localization of type I interleukin-1 receptor mRNA in the rat brain. Mol Brain Res 1994; 27: 27–36.
Katsuura G, Gottschall PE, Arimura A. Identification of a high-affinity receptor for interleukin-1 beta in rat brain. Biochem Biophys Res Commun 1988; 156: 61–7.
Farrar WM, Kilian PL, Ruff MR et al. Visualization and characterization of interleukin-1 receptors in brain. J Immunol 1987; 139: 459–63.
Reikerstorfer A, Holz H, Stunnenberg HG et al. Low affinity binding of interleukin-1 beta and intracellular signaling via NF-kappa B identify Fit-1 as a distant member of the interleukin-1 receptor family. J Biol Chem 1995; 270: 17645–8.
Takao T, Culp SG, De Souza EB. Reciprocal modulation of interleukin- 1β (IL-1β) and IL-1 receptors by lipopolysaccharide (endotoxin) treatment in the mouse brain-endocrine-immune axis. Endocrinology 1993; 132: 1497–504.
Takao T, Nakata H, Tojo C et al. Regulation of interleukin-1 receptors and hypothalamic-pituitary-adrenal axis by lipopolysaccharide treatment in the mouse. Brain Res 1994; 649: 265–70.
Lieberman AP, Pitha PM, Shin HS et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a nerotropic virus. Proc Natl Acad Sci USA 1989; 86: 6348–52.
Michie HR, Spriggs DR, Monogue KR et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988; 104: 280–6.
Butler LD, Layman NK, Riedl PE et al. Neuroendocrine regulation of in vivo cytokine production and effects. I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-a. J Neuroimmunol 1989; 24: 143–53.
Haour F, Ban E, Milon G et al. Brain interleukin 1 receptors: characterization and modulation after lopopolysacharide injection. Prog Neuro Endocrin Immunol 1990; 3: 196–204.
Rights and permissions
Copyright information
© 1996 R.G. Landes Company
About this chapter
Cite this chapter
Liu, C., Takao, T., Hashimoto, K., De Souza, E.B. (1996). Interleukin-1 Receptors in the Nervous System. In: Cytokines in the Nervous System. Neuroscience Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9695-0_3
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9695-0_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9697-4
Online ISBN: 978-1-4615-9695-0
eBook Packages: Springer Book Archive